NO992914D0 - Asymmetrisk syntese av benzoksazinoner - Google Patents

Asymmetrisk syntese av benzoksazinoner

Info

Publication number
NO992914D0
NO992914D0 NO992914A NO992914A NO992914D0 NO 992914 D0 NO992914 D0 NO 992914D0 NO 992914 A NO992914 A NO 992914A NO 992914 A NO992914 A NO 992914A NO 992914 D0 NO992914 D0 NO 992914D0
Authority
NO
Norway
Prior art keywords
alkyl
give
asymmetric synthesis
agent
alkylthio
Prior art date
Application number
NO992914A
Other languages
English (en)
Other versions
NO992914L (no
NO313236B1 (no
Inventor
Michael Ernest Pierce
Anusuya Choudhury
Jr Rodney Lawrence Parsons
Lilian Alicia Radesca
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of NO992914D0 publication Critical patent/NO992914D0/no
Publication of NO992914L publication Critical patent/NO992914L/no
Publication of NO313236B1 publication Critical patent/NO313236B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
NO19992914A 1996-12-16 1999-06-15 Asymmetrisk syntese av benzoksazinoner NO313236B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3298096P 1996-12-16 1996-12-16
US08/838,838 US5932726A (en) 1996-12-16 1997-04-11 Asymmetric synthesis of benzoxazinones
PCT/US1997/022674 WO1998027073A1 (en) 1996-12-16 1997-12-15 Asymmetric synthesis of benzoxazinones

Publications (3)

Publication Number Publication Date
NO992914D0 true NO992914D0 (no) 1999-06-15
NO992914L NO992914L (no) 1999-06-15
NO313236B1 NO313236B1 (no) 2002-09-02

Family

ID=26709131

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992914A NO313236B1 (no) 1996-12-16 1999-06-15 Asymmetrisk syntese av benzoksazinoner

Country Status (27)

Country Link
US (1) US5932726A (no)
EP (1) EP0944610B1 (no)
JP (1) JP4232911B2 (no)
KR (1) KR100498665B1 (no)
CN (1) CN1075063C (no)
AT (1) ATE289296T1 (no)
AU (1) AU750047B2 (no)
BR (1) BR9714031A (no)
CA (1) CA2275323C (no)
CZ (1) CZ297168B6 (no)
DE (1) DE69732525T2 (no)
EA (1) EA002987B1 (no)
EE (1) EE03920B1 (no)
ES (1) ES2235265T3 (no)
HR (1) HRP970688A2 (no)
HU (1) HU225655B1 (no)
IL (2) IL130684A (no)
LV (1) LV12432B (no)
NO (1) NO313236B1 (no)
NZ (1) NZ336163A (no)
PL (1) PL192661B1 (no)
PT (1) PT944610E (no)
RO (1) RO120844B1 (no)
SI (1) SI20071A (no)
SK (1) SK285258B6 (no)
UA (1) UA66773C2 (no)
WO (1) WO1998027073A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874430A (en) 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US6673372B1 (en) 1998-06-11 2004-01-06 Bristol-Myers Squibb Pharma Company Crystalline Efavirenz
TWI326283B (en) * 2002-07-31 2010-06-21 Du Pont Method for preparing fused oxazinones
EP1614672B1 (en) * 2003-04-04 2010-09-22 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
EP2313379B1 (en) * 2008-05-30 2015-03-11 Emcure Pharmaceuticals Limited Process for the preparation of efavirenz
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
CN101844990B (zh) * 2010-05-27 2013-03-20 浙江沙星医药化工有限公司 中间体4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的合成方法
EP2441759A1 (en) * 2010-10-14 2012-04-18 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2447255A1 (en) * 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
CN103664816B (zh) * 2011-01-06 2016-03-02 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺
WO2015118515A1 (en) * 2014-02-10 2015-08-13 Discovery Intermediates Private Limited An improved process for the preparation of a non-nucleoside reverse transcriptase inhibitor
EP2944631A1 (en) * 2014-05-12 2015-11-18 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of Efavirenz
CN104016936B (zh) * 2014-06-18 2016-08-17 中国科学院上海有机化学研究所 手性氨基酚配体在依法韦仑不对称合成中的应用
CN105801442A (zh) * 2015-10-16 2016-07-27 浙江沙星医药化工有限公司 4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的制备方法
KR102644663B1 (ko) * 2015-12-08 2024-03-07 디아이씨 가부시끼가이샤 옥사진 화합물, 조성물 및 경화물
KR102644662B1 (ko) * 2015-12-08 2024-03-07 디아이씨 가부시끼가이샤 옥사진 화합물, 조성물 및 경화물
JP6268565B2 (ja) * 2015-12-08 2018-01-31 Dic株式会社 オキサジン化合物、組成物及び硬化物
NL2018412B1 (en) * 2017-02-23 2018-09-17 Univ Nelson Mandela Metropolitan Method for the manufacture of efavirenz

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE343057C (de) * 1914-06-21 1921-10-25 Kalle & Co Aktien Ges Verfahren zur Darstellung von 1-Arylamino-4-oxynaphthalinen
US3280120A (en) * 1964-03-09 1966-10-18 Rexall Drug Chemical Substituted benzoxazines, process therefor and intermediates
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
US3513166A (en) * 1967-05-22 1970-05-19 Robins Co Inc A H 3-(omega-aminoalkyl)-4-substituted-1,3-benzoxazine-2-ones
AU5960380A (en) * 1979-08-30 1981-03-05 A. Ehrenreich G.m.b.H. & Co. KG Bellows seal and retaining ring
DE3622262A1 (de) * 1986-07-02 1988-01-07 Bayer Ag Chromogene 3,1-benzoxazine
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
AU1694295A (en) * 1994-01-28 1995-08-15 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5663467A (en) * 1995-01-23 1997-09-02 Merck & Co., Inc. Synthesis of cyclopropylacetylene
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one

Also Published As

Publication number Publication date
HRP970688A2 (en) 1998-10-31
CN1075063C (zh) 2001-11-21
SK80399A3 (en) 2000-03-13
CZ297168B6 (cs) 2006-09-13
KR20000057574A (ko) 2000-09-25
AU5694498A (en) 1998-07-15
PL334281A1 (en) 2000-02-14
PT944610E (pt) 2005-04-29
UA66773C2 (uk) 2004-06-15
EP0944610A1 (en) 1999-09-29
HUP0000168A2 (hu) 2000-09-28
CA2275323A1 (en) 1998-06-25
JP2001507684A (ja) 2001-06-12
NZ336163A (en) 2001-04-27
ES2235265T3 (es) 2005-07-01
SI20071A (sl) 2000-04-30
NO992914L (no) 1999-06-15
JP4232911B2 (ja) 2009-03-04
ATE289296T1 (de) 2005-03-15
EA002987B1 (ru) 2002-12-26
DE69732525T2 (de) 2006-01-12
US5932726A (en) 1999-08-03
CN1245493A (zh) 2000-02-23
HUP0000168A3 (en) 2001-02-28
LV12432A (lv) 2000-02-20
SK285258B6 (sk) 2006-10-05
AU750047B2 (en) 2002-07-11
BR9714031A (pt) 2000-05-09
HU225655B1 (en) 2007-05-29
PL192661B1 (pl) 2006-11-30
LV12432B (en) 2000-07-20
NO313236B1 (no) 2002-09-02
RO120844B1 (ro) 2006-08-30
EE9900243A (et) 1999-12-15
WO1998027073A8 (en) 1999-11-04
IL130684A0 (en) 2000-06-01
KR100498665B1 (ko) 2005-07-01
CA2275323C (en) 2003-04-08
EE03920B1 (et) 2002-12-16
CZ212899A3 (cs) 1999-11-17
EA199900552A1 (ru) 2000-02-28
WO1998027073A1 (en) 1998-06-25
IL130684A (en) 2003-12-10
DE69732525D1 (de) 2005-03-24
EP0944610B1 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
NO992914D0 (no) Asymmetrisk syntese av benzoksazinoner
DE59806330D1 (de) Synergistische Flammschutzmittel-Kombination für Kunststoffe
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
KR960017675A (ko) 유기물질에 대한 안정화제로서 실란기를 포함하는 피페리딘 화합물
CS621987A2 (en) Coating composition
FR2699918B1 (fr) Ligands sélectifs des récepteurs 5HY1D-5HT1B dérivés d'indole-pipérazine utiles comme médicaments.
PT73338A (de) 3,1-benzoxazin-2-one ihre herstellung und verwendung
ES8401030A1 (es) Un procedimiento para la preparacion de indol sulfonilureas.
GB2183476B (en) Anthihypertensive combination product
ATE83234T1 (de) Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung.
DE69115138D1 (de) Verfahren zur herstellung von ergolinderivaten.
ATE1904T1 (de) 2-sulfonyl-chinoxaline, verfahren zu ihrer herstellung sowie ihre verwendung als mikrobizide.
DE59712053D1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
PE119599A1 (es) Tetrahidronaftalenos sustituidos y compuestos analogos
IL116386A0 (en) Use of 1,2 bridged 1,4 dihydropyridines and process for their prepration
ATE97409T1 (de) Benzodiazepin-analoge.
DE59712054D1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
MX9801955A (es) Mezclas herbicidas con accion sinergetica.
ATE12767T1 (de) Substituierte oximinoacetanilide, verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel.

Legal Events

Date Code Title Description
MK1K Patent expired